These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 15034487)

  • 1. [Treatment of Alzheimer's disease: general methodological aspects].
    Gauthier S
    Rev Neurol (Paris); 2004 Feb; 160(2):261-4. PubMed ID: 15034487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trials to slow progression and prevent disease onset.
    Thal LJ
    J Neural Transm Suppl; 2000; 59():243-9. PubMed ID: 10961435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disease modifying trials in Alzheimer's disease: perspectives for the future.
    Vellas B; Coley N; Andrieu S
    J Alzheimers Dis; 2008 Oct; 15(2):289-301. PubMed ID: 18953115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genentech's Alzheimer's antibody trial to study disease prevention.
    Garber K
    Nat Biotechnol; 2012 Aug; 30(8):731-2. PubMed ID: 22871696
    [No Abstract]   [Full Text] [Related]  

  • 5. Defining and labeling disease-modifying treatments for Alzheimer's disease.
    Cummings JL
    Alzheimers Dement; 2009 Sep; 5(5):406-18. PubMed ID: 19751920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The DIAN-TU Next Generation Alzheimer's prevention trial: Adaptive design and disease progression model.
    Bateman RJ; Benzinger TL; Berry S; Clifford DB; Duggan C; Fagan AM; Fanning K; Farlow MR; Hassenstab J; McDade EM; Mills S; Paumier K; Quintana M; Salloway SP; Santacruz A; Schneider LS; Wang G; Xiong C;
    Alzheimers Dement; 2017 Jan; 13(1):8-19. PubMed ID: 27583651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using cognitive decline in novel trial designs for primary prevention and early disease-modifying therapy trials of Alzheimer's disease.
    Darby D; Brodtmann A; Woodward M; Budge M; Maruff P
    Int Psychogeriatr; 2011 Nov; 23(9):1376-85. PubMed ID: 21477408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of COVID-19 on preclinical and clinical research in neurology: Examples from research on neurodegeneration and Alzheimer's disease.
    Snider BJ; Holtzman DM
    Neuron; 2021 Oct; 109(20):3199-3202. PubMed ID: 34525328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of sporadic Alzheimer's disease: lessons learned from clinical trials and future directions.
    Andrieu S; Coley N; Lovestone S; Aisen PS; Vellas B
    Lancet Neurol; 2015 Sep; 14(9):926-944. PubMed ID: 26213339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alzheimer's drugs take a new tack.
    Callaway E
    Nature; 2012 Sep; 489(7414):13-4. PubMed ID: 22962697
    [No Abstract]   [Full Text] [Related]  

  • 11. The Alzheimer's Disease Cooperative Study in 2004.
    Thal LJ
    Alzheimer Dis Assoc Disord; 2004; 18(4):183-5. PubMed ID: 15592126
    [No Abstract]   [Full Text] [Related]  

  • 12. Preventing Alzheimer's disease.
    Selkoe DJ
    Science; 2012 Sep; 337(6101):1488-92. PubMed ID: 22997326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New approaches to diagnose and treat Alzheimer's disease: a glimpse of the future.
    Galasko D
    Clin Geriatr Med; 2001 May; 17(2):393-410. PubMed ID: 11375142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention Trials in Alzheimer's Disease: Current Status and Future Perspectives.
    Wang J; Tan L; Yu JT
    J Alzheimers Dis; 2016; 50(4):927-45. PubMed ID: 26836177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Addressing the challenges of transforming laboratory advances into Alzheimer's Disease treatments.
    Karlawish JH; Clark CM
    Neurobiol Aging; 2002; 23(6):1043-9. PubMed ID: 12470801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes for disease modifying trials.
    Wilcok G
    J Nutr Health Aging; 2007; 11(4):318-9. PubMed ID: 17653489
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical trials in Alzheimer's disease. A report from the Medical Research Council Alzheimer's Disease Clinical Trials Committee.
    Swash M; Brooks DN; Day NE; Frith CD; Levy R; Warlow CP
    J Neurol Neurosurg Psychiatry; 1991 Feb; 54(2):178-81. PubMed ID: 1843446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An individualized approach to tracking and treating Alzheimer's disease.
    Rockwood K
    Clin Pharmacol Ther; 2010 Oct; 88(4):446-9. PubMed ID: 20856240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Obstacles and opportunities in Alzheimer's clinical trial recruitment.
    Watson JL; Ryan L; Silverberg N; Cahan V; Bernard MA
    Health Aff (Millwood); 2014 Apr; 33(4):574-9. PubMed ID: 24711317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Commentary on "A roadmap for the prevention of dementia II. Leon Thal Symposium 2008." Who may benefit from disease-modifying studies in Alzheimer's disease?
    Gauthier S; Poirier J
    Alzheimers Dement; 2009 Mar; 5(2):147-8. PubMed ID: 19328447
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.